Objective: To evaluate if a family presence educational intervention during brain death evaluation improves understanding of brain death without affecting psychological distress. Design: Randomized controlled trial. Setting: Four ICUs at an academic tertiary care center. Subjects: Immediate family members of patients suspected to have suffered brain death. Interventions: Subjects were group randomized to presence or absence at bedside throughout the brain death evaluation with a trained chaperone. All randomized subjects were administered a validated "understanding brain death" survey before and after the intervention. Subjects were assessed for psychological well-being between 30 and 90 days after the intervention. Measurements and Main Results: Follow-up assessment of psychological well-being was performed using the Impact of Event Scale and General Health Questionnaire. Brain death understanding, Impact of Event Scale, and General Health Questionnaire scores were analyzed using Wilcoxon nonparametric tests. Analyses were adjusted for within family correlation. Fifty-eight family members of 17 patients undergoing brain death evaluation were enrolled: 38 family members were present for 11 brain death evaluations and 20 family members were absent for six brain death evaluations. Baseline understanding scores were similar between groups (median 3.0 [presence group] vs 2.5 [control], p = 0.482). Scores increased by a median of 2 (interquartile range, 1-2) if present versus 0 (interquartile range, 0-0) if absent (p < 0.001). Sixty-six percent of those in the intervention group achieved perfect postintervention "understanding" scores, compared with 20% of subjects who were not present (p = 0.02). Median Impact of Event Scale and General Health Questionnaire scores were similar between groups at follow-up (Impact of Event Scale: present = 20.5, absent = 23.5, p = 0.211; General Health Questionnaire: present = 13.5, absent = 13.0, p = 0.250). Conclusions: Family presence during brain death evaluation improves understanding of brain death with no apparent adverse impact on psychological well-being. Family presence during brain death evaluation is feasible and safe. (Crit Care Med 2014; 42:934-942) 
demonstrated that presence during resuscitation does not appear to put family members at risk of additional psychological stress (1, 2, 6) .
A related controversial issue is that of family presence during the clinical brain death evaluation (BDE). Brain death is often misunderstood by laypersons; thus, in addition to potentially facilitating adjustment to death and grieving, presence during the BDE may serve to improve understanding and reduce misconceptions (7, 8) . This subject has been the focus of several opinion articles, with some authors espousing the merits of this approach (9-11) and others voicing concern over such a strategy worsening psychological distress (12, 13) . Additional concerns over a family presence strategy include worry that family members might be disruptive to the care process and fear of increased litigation. Published reports indicate that clinicians who have experienced family member presence during BDE believed that observing the testing was helpful to those relatives and that the involved family were pleased to have been present and did not suffer greater anxiety and depression following the experience (11, 12) . Currently, however, family presence during BDE is not standard practice, and no prospective controlled trial has empirically evaluated family presence during brain death testing.
The specific aims for this study were to determine whether family presence during the BDE affects family member understanding of brain death and to determine whether family presence during the BDE impacts the distress experienced by the family members. We also report our experience with consent for organ donation among family members who did and did not witness the BDE.
MATERIALS AND METHODS
This study, conducted between January 2009 and June 2011, was approved by the Human Research Review Committee of the University of New Mexico (UNM) Health Sciences Center. All study subjects signed written informed consent prior to participation.
Design and Setting
This was a prospective, randomized controlled trial conducted in the medical ICU, neurosciences ICU, trauma/surgical ICU, and PICU at the UNM hospital in Albuquerque, NM. The UNM hospital is a 545-bed tertiary teaching hospital and level 1 trauma center serving a catchment population of approximately 2 million. All BDEs at UNM hospital are performed by critical care team physicians who specialize in intensive care, neurosurgery, general surgery, or internal medicine. Once brain death is suspected, a team of family care and donation specialists working for New Mexico Donor Services (NMDS) provides family support. Only after brain death is confirmed, do NMDS and UNM hospital caregivers make requests for organ donation following protocols and guidelines consistent with national organ procurement standards.
Subjects
Subjects were adult (> 17 yr old) immediate family members of patients whom the treating physician suspected had suffered brain death. Potential subjects were excluded if they were unable to provide consent; if they had been significantly injured in the same event causing their loved one's injury (e.g., car crash); if they did not speak English as a primary language; or if they had any visual and/or hearing deficit that precluded their observation of the BDE.
Experimental Protocol
Prior to performing the initial clinical BDE, up to five eligible immediate family members present at the time of the decision to conduct the BDE were asked to provide informed consent for participation in the study. Subjects who consented to participation were then randomized as a family group, using a computer-generated sequence, to either bedside presence or absence during the initial BDE.
After randomization and before observation of the BDE, subjects were asked to provide some basic demographic information, including their age, sex, level of education, and prior experience with brain death or persistent vegetative states. The subjects also completed a previously validated 5-item questionnaire measuring understanding of brain death ( Table 1 ) (14) . These questions are not part of the "understanding brain death" questionnaire and were included in this study solely for research purposes. Family groups randomized to be present during the BDE then joined the evaluating physician at the patient's bedside to observe the BDE including all brainstem reflex testing and the apnea test. The subjects were accompanied by a chaperone from NMDS who could explain the process and answer questions during the evaluation. Family groups randomized to be absent during the BDE waited in an adjacent room, also accompanied by an NMDS chaperone, until the evaluation was completed. During this time, all family members (whether or not they were participating in the study) received psychosocial support from a representative from NMDS as is standard practice at our institution. This support included answering all questions related to the diagnostic process for brain death but did not include any mention of organ donation.
The BDE process followed our institutional guideline and was consistent with the most recent practice guidelines of the American Academy of Neurology (15) . When the complete clinical BDE could not be completed (e.g., facial trauma precluding pupillary assessment or cardiopulmonary instability obviating the performance of an apnea test), brain death was evaluated using a cerebral imaging study. In this scenario, the study subjects randomized to the intervention arm were shown the images and received an explanation of their significance.
After the BDE was complete, the family members were notified of the results and given an opportunity to ask questions and have them answered. Subjects were then asked to complete the 5-item questionnaire on understanding brain death once again; subjects randomized to be present during the BDE were asked two additional questions evaluating the experience of being present (Table 1) .
For patients in whom brainstem death was confirmed, the appropriate family member or legally authorized representative was then approached by an NMDS representative to discuss the option of organ donation. This process did not differ from the standard care provided to all family members in this situation in our institution.
We used the Impact of Event Scale (IES) and General Health Questionnaire-12 (GHQ-12) surveys to measure the emotional and psychological impact of the BDE experience. The IES has been validated to quantify the subjective distress for any life event including death and bereavement. It is one of the earliest measures of posttraumatic disturbance, measuring both the frequency of intrusive thoughts and attempts at avoidance of reminders relating to the recent event (16) . The GHQ-12 assesses the respondent's current psychiatric state and whether that differs from their usual state. It is sensitive for short-term psychiatric disorders but not for long-standing disorders (17) , and it incorporates measures of anxiety, depression, social dysfunction, and loss of confidence (18, 19) . These scales have been used previously to assess the psychological impact of bereavement, witnessed resuscitation, and witnessing BDE (2, 10, 16) . One month after the BDE, all subjects were sent hard copies of the IES and GHQ-12 surveys; subjects were then contacted by telephone by a trained research nurse who administered the two surveys and recorded the subjects' responses over the telephone. At least three attempts were made to contact each subject. Subjects who could not be contacted within 90 days of the BDE were considered lost to follow-up.
Key Outcomes and Statistical Analysis
To evaluate understanding of brain death, differences between pre-and postintervention performance on the 5-item understanding brain death questionnaire for the control and intervention groups were evaluated. To evaluate the psychological distress experienced by the two study groups, differences in IES and GHQ-12 scores were evaluated. Organ donation consent rates for the two groups are also reported.
Baseline demographic characteristics, including brain death understanding scores for the two study groups were compared using Wilcoxon rank-sum test, t test, and Fisher exact test as appropriate. Differences in pre-and postintervention brain death understanding scores were also analyzed using the Wilcoxon rank-sum test. To adjust for the potential correlation in psychological distress within family member groups who observed the same BDE, postintervention IES scores and GHQ-12 scores were analyzed using Wilcoxon rank-sum test with the incorporation of clustered data effects as described by Rosner et al (20) and Rosner and Grove (21) . This allowed us to account for the repeated measurements made on the same BDE and for potential cluster effects observed within families due to our group randomization process. Analyses were performed using SPSS Version 19 (IBM Company, Armonk, NY), with additional manual calculations as necessary for the incorporation of cluster effects. For all analyses, a two-tailed α value of 0.05 was used to establish statistical significance.
An a priori power analysis indicated that 28 subjects per arm would provide 80% power to detect a one point difference in understanding of brain death questionnaire scores; 38 subjects would provide 80% power to detect a 6-point difference in GHQ-12 scores, and 60 subjects per arm would be required to achieve 80% power to detect a 10-point difference in IES scores.
RESULTS
Between January 2009 and June 2011, 30 families of patients undergoing BDE were approached about the study. Thirteen families declined to participate: 12 families were unwilling to submit to randomization (eight insisting on presence; four insisting on absence) and one family was too distraught to complete the consent process. The family members of 17 patients undergoing BDE consented to participate, with 58 individuals enrolled in the study. Although we had not yet achieved our a priori sample size, enrollment in the study was stopped prematurely because of a de facto move among nurses and physicians to offer the family presence option during the BDE.
Thirty-eight family members of 11 patients were randomized to be present during the BDE, and 20 family members of six patients were randomized to be absent during the BDE. The demographic characteristics, including the baseline understanding of brain death scores, for both the patients and the participants represented in the two study groups are shown in Table 2 . The patients with family members randomized to be present during the BDE had longer ICU stays than the patients with family members randomized to absence (median 0.8 vs 1.6 d); otherwise, there were no significant differences between the two patient groups. There was no difference in baseline understanding of brain death, with median scores of 3.0 among subjects randomized to be present for the BDE and 2.5 for the subjects randomized to be absent (p = 0.482).
All randomized subjects completed the study protocol in their assigned groups. Subjects who were randomized to observe the BDE had significantly higher postevaluation understanding of brain death scores than subjects who were randomized to be absent (median 5.0 vs 2.5, p < 0.001) ( Fig. 1 ; Table 3 ). Understanding of brain death scores increased among subjects randomized to be present for the evaluation (median change, 2; interquartile range [IQR], 1-2), whereas understanding of brain death scores were unchanged among subjects randomized to be absent (median change, 0; IQR, 0-0) (p < 0.001). Twenty-five subjects (66%) randomized to be present for the BDE achieved perfect postintervention understanding of brain death scores, compared with four subjects (20%) who were randomized to be absent (chi-square, p = 0.02). Thirty-six of the 38 subjects (94.7%) present during BDE reported that being present helped them understand brain death, and 32 (84.2%) said they would recommend family presence to others in the same situation. Follow-up IES and GHQ-12 data were obtained from 41 subjects (71%): 24 subjects (63%) randomized to be present for the BDE and 17 subjects (85%) randomized to be absent. The IES and GHQ-12 scores were similar for the two study groups ( Fig. 2; Table 3 ). Median IES scores for the subjects randomized to be present during the BDE were 20.5 (IQR, 13.5-41.5), compared with median scores of 23.5 (IQR, 11.3-40.5) for those subjects randomized to be absent (p = 0.211). These same similarities were seen in the subscales of the IES (Table 3) . Median GHQ-12 scores were also similar between the study groups, with median scores of 13.5 (IQR, 11.3-16.8) for subjects randomized to be present during the BDE and 13 (IQR, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] for subjects randomized to be absent (p = 0.187). There were no reported adverse events during the study period and on no occasion was the BDE or patient care interrupted by a family member present at the bedside.
Brain death was confirmed in all 17 patients. Organ procurement was pursued for 16 of the 17 patients with family members enrolled in the study. First person consent (by way of a donor registry) for organ donation occurred in 10 patients. Of the remaining six patients, family consented for donation in four cases and refused consent in two cases. Refusal for donation came from one family randomized to presence and one family randomized to the control group.
DISCUSSION
These data demonstrate that family member presence at the patient's bedside during the BDE increases the family members' understanding of brain death, with no indication of increased emotional or psychological distress in this sample. These findings confirm previous anecdotal reports describing family member presence during the BDE (9-12, 22), as well as studies evaluating family member presence during resuscitations and other emergency procedures (1-6), and now add empirical evidence supporting the practice. Brain death is an exceptionally difficult concept to understand. For example, a recent study using the same understanding of brain death tool that we used reported that only 39% of fourth year medical students demonstrated expert understanding of brain death (23) . Even among medical experts, complete understanding of brain death is not universal, evidenced by two of 13 "experts" participating in the validation study of the brain death understanding tool answering at least one of the questions incorrectly (14) . Other studies have identified misconceptions regarding brain death among experienced physicians (24, 25) . Thus, it should not be surprising that laypersons have trouble reconciling brain death, particularly its irreversibility and equivalence to their understanding of "conventional death." In fact, as many as one third of relatives of patients diagnosed with brain death do not understand that death has occurred (26, 27) . Even those families who reported that brain death had been explained to them did not show significantly greater knowledge about brain death compared with those who did not recall being provided an explanation (27) . Survey studies have discovered that patient's families often consent to organ donation on their behalf without a clear understanding of brain death (28) (29) (30) . One study found that next of kin who decided against donation had far less understanding of brain death than did those who decided in favor of it (27) . Hence, there is a need for a more effective way of educating families during this emotionally charged and stressful time (13, 31) .
The effect of the improved understanding of brain death using a family presence strategy on consent for organ donation remains to be determined. We cannot draw any statistically sound conclusions about donation consent rates from our limited data. More than half of the consents for organ donation at our institution are the result of "first person consent," by indication on the patient's driver's license or donor registry. Our surrogate consent rate from family members of the remaining patients is approximately 55%. We estimate that a sample of 163 subjects per study arm would be required to provide 80% power to detect an increase in indirect consent rates from 55% to 70%, which would require a large, multicenter trial. However, we believe that a family presence strategy has significant merit, independent of its impact on organ donation consent. A family presence strategy responds to continued family and patient requests to be better educated and more empowered within our current healthcare system (26, 28, 31, 32) . As stated nearly 10 years ago in a review on the topic; "It is no longer acceptable for doctors and nurses to have the benefit of witnessing confirmation of death whilst expecting the relatives to accept brainstem death in the face of so much apparent life" (22) . We hope that these data bring us closer to addressing this concern.
We found no evidence of increased emotional or psychological distress among subjects randomized to be present for the BDE as measured by GHQ-12 and IES, including the IES intrusion and avoidance subscales. Although we did not achieve the sample size suggested by our a priori power analysis, we are confident in these findings. The differences in the GHQ-12 and IES scores are too small to be clinically relevant, independent of any statistical findings. Previous studies have found mean IES scores of 39.5 ± 17.2 in bereaved and injured persons (16) . We found lower IES scores, in the range of 20-30, for subjects in both arms of our study. Furthermore, subjects randomized to be present had lower IES scores than those randomized to be absent (20.5 vs 23.5) ( Table 4) . This is consistent with the findings of Jabre et al (1), who reported a reduction in IES score when subjects observed resuscitations. Similarly, previous studies have reported mean GHQ-12 scores of 30-32 in subjects with depression or anxiety (17, 33) . The subjects in our study had markedly lower GHQ-12 scores that differed by only half a point between the two groups ( Table 3) . Most of the subjects (94.7%) present during BDE reported that being present helped them understand brain death, and 84.2% said they would recommend family presence to others. Several subjects expressed gratitude for the experience, with comments like, "Being present helped me understand that it is only the machines keeping the heart beating." Two subjects who were randomized to not be present expressed regret that they were absent.
There were some notable differences in the demographic makeup of the two study groups, with more women among the group randomized to be absent from the BDE and more parents among the group randomized to be present. In a post hoc analysis of these potential confounders, we found no association between GHQ-12 or IES and subject sex, race, ethnicity, or being a parent. This was true both in the overall data and within the randomization groups. There was also no association between IES and education, although we did find an association between GHQ-12 and education among subjects randomized to be present. In that study group, subjects who had a high school education or less had higher GHQ-12 scores (median, 16; IQR, 13-24) when compared with subjects who had more than a high school education (median, 13; IQR, 11-14) (p = 0.038), but this 3-point difference in GHQ-12 is not clinically meaningful. There was no association between GHQ-12 and IES among subjects randomized to be absent from the BDE or in the overall data. Table 4 shows the GHQ-12 and IES stratified by subject demographics.
These IES and GHQ-12 data must not be interpreted as meaning the experience of a loved one's suffering brain death is not distressing or that presence during the BDE mitigates that distress. As one subject noted, "Opening the eyes was graphic and family should be prepared for this." Several subjects in both arms of the study reported negative effects of the experience, with IES scores as high as 71 and GHQ-12 scores as high as 36. This emphasizes the importance of trained chaperones during the BDE process.
In implementing a family presence strategy, it is important to understand and anticipate potential challenges in order to optimize outcomes. The intervention in this trial went beyond simply having the family members be present; this was an educational intervention with a dedicated NMDS chaperone responsible for the subjects' well-being during BDE and their education. This chaperone, along with the physician performing the BDE, took care to explain each step of the examination and the significance of the findings. The chaperones in our study have dual appointments with NMDS and UNM hospital. They play an important role as family care coordinators independent from our study. They do not influence the BDE results, and they do not raise the issue of organ donation until after the BDE is complete. This family support role by organ procurement organizations has been well described and is widely accepted as not creating a conflict of interest (34, 35) . We chose to limit presence to no more than five family members, because of physical space constraints and concerns about compromising the effectiveness of teaching. Other programs may have different limitations. Additionally, the clinicians and family educators must be prepared for unanticipated outcomes, including the presence of brainstem reflexes, the presence of spinal cord reflexes, and clinical deterioration that may require aborting the evaluation (particularly the apnea test).
In our cohort, we had one examination manifest spinal cord reflexes, and one case with unanticipated inability to complete apnea testing. Both cases went smoothly from the clinicians' perspective, and the family members in these cases unanimously reported that they would recommend family presence during BDE. There were no cases where the BDE was negative for brain death. The physicians, nurses, family care providers, and donor services personnel were not formally polled regarding their satisfaction with the family presence strategy. However, throughout the latter part of the study, an increasing number of potential subjects were not enrolled due to clinicians' perception that they may benefit from presence during BDE. Study enrollment suffered as physicians and nurses began offering the opportunity for presence to family members outside of the study protocol, feeling that family members should be given the choice of presence versus absence. This led to the sample size and power limitations of this study that have been discussed above. If the nurses and physicians preferentially offered bedside presence to those families who they anticipated would fare well, that could have introduced some selection bias in our study. However, any bias resulting from individuals anticipated to respond poorly to bedside presence being enrolled in the study should have increased the likelihood of us finding some detrimental influence of the practice. Another limitation of this study is that it was performed at a single tertiary care hospital. The results might not be applicable to regional or community hospitals that do not have sufficient resources to support family members during the BDE process, most notably trained chaperones who can explain the process and answer family member questions. We did not record or control for additional family-staff interactions that might increase brain death understanding, such as familiarity with the physician performing the BDE or family conferences or family participation in bedside rounds. These types of clinician-family interactions are not routine at UNM hospital but do sometimes occur and might affect understanding of brain death and/or the emotional distress associated with the experience.
The subjects in the study were family members who were willing to be randomized; others who insisted on presence or absence were excluded, so our results might not fully reflect outcomes for family members who have a clear, preconceived preference. Furthermore, the IES and GHQ-12 may not completely capture the emotional distress associated with the BDE experience as those effects might manifest over a longer time period, or they might manifest and dissipate over a shorter time period. Finally, nearly 30% of our subjects were lost to IES and GHQ-12 follow-up, and this was worse among subjects present for the BDE (37%) than among those absent (15%). If loss to follow-up is somehow associated with adverse outcomes, we could be underestimating the emotional and psychological effects of presence during BDE. However, in a post hoc sensitivity analysis in which all subjects lost to follow-up were assigned the highest observed IES (71) 
CONCLUSIONS
Family member presence at the beside during the brain death examination increases the family member's understanding of brain death apparently without increasing their risk of emotional or psychological distress. The effect of family member presence during the brain death examination on consent for organ donation remains to be determined.
